Fabrinet Operating Cash Flow increased by 14.4% to $52.93M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 28.7%, from $74.19M to $52.93M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 28.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.84M | $36.91M | $20.66M | $50.33M | $16.35M | $60.63M | $44.47M | $37.12M | $71.09M | $145.05M | $84.17M | $100.87M | $83.06M | $83.18M | $115.90M | $74.19M | $55.09M | $102.57M | $46.26M | $52.93M |
| QoQ Change | — | -13.8% | -44.0% | +143.6% | -67.5% | +270.9% | -26.7% | -16.5% | +91.5% | +104.0% | -42.0% | +19.8% | -17.7% | +0.1% | +39.3% | -36.0% | -25.7% | +86.2% | -54.9% | +14.4% |
| YoY Change | — | — | — | — | -61.8% | +64.3% | +115.3% | -26.2% | +334.8% | +139.2% | +89.3% | +171.7% | +16.8% | -42.7% | +37.7% | -26.5% | -33.7% | +23.3% | -60.1% | -28.7% |